This 2019 review examines the role of vitamin C (ascorbic acid) as an adjunct in cancer therapy. At pharmacological concentrations, vitamin C exhibits pro-oxidant properties, generating reactive oxygen species that selectively induce cytotoxicity in cancer cells. It also modulates epigenetic mechanisms by influencing DNA and histone demethylation, affecting gene expression
